The American Society of Hematology (ASH) Annual Meeting was held December 6-9 in San Francisco, California. This meeting was attended by more than 20,000 hematologists, oncologists, and allied health professionals, who gathered to report and learn about significant new research findings from around the world.
Symposium: MDS and MDS/MPN Past, Present, and Future
This symposium, presented in collaboration with Cleveland Clinic, presented the most up-to-date diagnostic and treatment options for MDS and MDS/MPN overlap syndromes. This event featured an internationally renowned faculty and drew an audience of nearly 500 hematologists and other allied health professionals.
A written summary of the symposium presentations for patients and video interviews with all of the presenters are now available.
Poster Session
Dr. Aaron T. Gerds with Cleveland Clinic provided an oral poster presentation of the collaborative study on communication conducted by AA&MDSIF and Cleveland Clinic. The poster described differences between how patients and their physicians view reasons for treatment discontinuation. Ongoing education declines over time, even as patients return for follow-up visits. This study highlights the importance of continued patient education during medical appointments.
MDS Webinar
Watch an archived webinar with Dr. Benjamin Ebert and Dr. Mikkael Sekeres who presented a patient-focused highlight of the newest MDS research from at ASH.
Research Summaries
- Lay language summaries for aplastic anemia
- PNH Studies Summary Report: International PNH Interest Group Meeting ASH 2014
- A Summary of Selected Scientific Abstracts for Patients with Myelodysplastic Syndromes (MDS) and their Caregivers
Video Interviews with Experts
AA&MDSIF recorded interviews with our experts attending the ASH Annual Meeting to explain the most important new research on aplastic anemia, MDS, and PNH. These physicians are AA&MDSIF Medical Advisory Board members or AA&MDSIF research grant recipients who shared their time and expertise to discuss the latest advances in bone marrow failure disease research.
Watch these interviews on our YouTube channel:
 |
Dr. Neal Young of the National Heart, Lung, and Blood Institute and a member of the AA&MDSIF Medical Advisory Board, discusses the most important research about aplastic anemia reported at the 2014 American Society of Hematology Annual Meeting. Highlights include several promising new drug treatment options heading for clinical trials and increased understanding of the disease. Watch the video. |
 |
Dr. Benjamin Ebert of Brigham and Women's Hospital and a member of the AA&MDSIF Medical Advisory Board, discusses the most important research about MDS (myelodysplastic syndromes) reported at the 2014 American Society of Hematology Annual Meeting. Highlights include genetic mutations and targeting new treatment therapies. Low risk MDS clinical trials are discussed and bone marrow transplant protocols. Watch the video. |
 |
Dr. Carlos DeCastro of Duke University School of Medicine and a member of the AA&MDSIF Medical Advisory Board, discusses the most important research about PNH (paroxysmal nocturnal hemoglobinuria) reported at the 2014 American Society of Hematology Annual Meeting. Highlights include several promising new drug treatment options heading for clinical trials and increased understanding of the disease. Watch the video. |